SCHEMBL29618979

SCHEMBL29618979

CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ERAP2 Q6P179 2/20 0.53
ERAP1 Q9NZ08 1/20 0.53
LNPEP Q9UIQ6 1/20 0.53
NPY1R P25929 1/20 0.47
NPY2R P49146 1/20 0.47
NPY4R P50391 1/20 0.47
CPB2 Q96IY4 6/20 0.46
ALDH1A1 P00352 2/20 0.45
OPRK1 P41145 1/20 0.45
FOLH1 Q04609 2/20 0.45
NMT2 O60551 1/20 0.44
NMT1 P30419 1/20 0.44
MAPT P10636 1/20 0.44
GSR P00390 1/20 0.44
LAP3 P28838 2/20 0.43
MEN1 O00255 1/20 0.43
LMNA P02545 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29531650 1.00 ERAP2 (0.53) ERAP2ERAP1LNPEPNPY1RNPY2R
SCHEMBL29704544 0.99 ERAP2 (0.52) ERAP2ERAP1LNPEPNPY1RNPY2R
SCHEMBL30749119 0.99 ERAP2 (0.52) ERAP2ERAP1LNPEPNPY1RNPY2R
SCHEMBL30749124 0.99 ERAP2 (0.52) ERAP2ERAP1LNPEPNPY1RNPY2R
SCHEMBL29666891 0.96 ERAP2 (0.54) ERAP2ERAP1LNPEPNPY1RNPY2R
SCHEMBL29898192 0.96 ERAP2 (0.56) ERAP2ERAP1LNPEPNPY1RNPY2R
SCHEMBL30930157 0.95 NMT1 (0.52) ERAP2ERAP1LNPEPNPY1RNPY2R
SCHEMBL29438723 0.95 NMT1 (0.52) ERAP2ERAP1LNPEPNPY1RNPY2R
SCHEMBL30785147 0.94 ERAP2 (0.55) ERAP2ERAP1LNPEPNPY1RNPY2R
SCHEMBL29714947 0.94 ERAP2 (0.55) ERAP2ERAP1LNPEPNPY1RNPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024254043-A2 NMDA-R ACTIVATING PEPTIDES IN INFLAMMATION AND NEURONAL DIFFERENTIATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-12-12 WO disclosed
EP-4237445-A2 COMPOSITIONS AND METHODS FOR PREVENTING, INHIBITING, DISRUPTING, OR TREATING A POLYMICROBIAL BIOFILM Research Institute at Nationwide Children's Hospital (US) 2023-09-06 EP disclosed
EP-4178359-A2 COMBINATION THERAPIES FOR THE TREATMENT AND PREVENTION OF BIOFILMS Research Institute at Nationwide Children's Hospital (US) 2023-05-17 EP disclosed
EP-3997120-A2 ANTIBODY COMPOSITIONS FOR DISRUPTING BIOFILMS Research Institute at Nationwide Children's Hospital (US) 2022-05-18 EP disclosed
WO-2022094433-A2 COMPOSITIONS AND METHODS FOR PREVENTING, INHIBITING, DISRUPTING, OR TREATING A POLYMICROBIAL BIOFILM RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL (US) 2022-05-05 WO disclosed